See the DrugPatentWatch profile for cosentyx

Based on the information available, there is no definitive evidence to suggest that Cosentyx (secukinumab) directly leads to reduced vaccine protection. However, it is important to note that certain medications, including Cosentyx, can impact the immune system, which may in turn influence the effectiveness of vaccines [1].

Cosentyx is a prescription medication used to treat several autoimmune conditions, such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. As an interleukin-17A inhibitor, Cosentyx works by blocking the action of a specific protein involved in the body's immune response [1].

According to DrugPatentWatch.com, Cosentyx was first approved by the FDA in 2015, and its patents are set to expire in 2025 [2]. While the drug's mechanism of action can influence the immune system, there is no specific information regarding Cosentyx's impact on vaccine protection [1].

Nonetheless, the Centers for Disease Control and Prevention (CDC) recommends consulting a healthcare professional before administering vaccines to individuals on immunosuppressive therapies, such as Cosentyx, due to the potential impact on vaccine effectiveness [3].

In summary, while there is no direct evidence that Cosentyx leads to reduced vaccine protection, it is crucial to consult a healthcare professional before receiving vaccines while on immunosuppressive medications.

Sources:

1. Cosentyx (secukinumab) [Internet]. Mayo Clinic. 2022 [cited 2022 Mar 15]. Available from: https://www.mayoclinic.org/drugs-supplements/cosentyx-secukinumab-subcutaneous-route/description/drg-20165353
2. Secukinumab Drug Profile: Patent Expiry, Sales and Competitor Analysis - DrugPatentWatch [Internet]. DrugPatentWatch.com. 2022 [cited 2022 Mar 15]. Available from: https://www.drugpatentwatch.com/drugs/secukinumab
3. Recommendations of the Advisory Committee on Immunization Practices for Use of COVID-19 Vaccines - United States, 2021 [Internet]. Centers for Disease Control and Prevention. 2021 [cited 2022 Mar 15]. Available from: https://www.cdc.gov/mmwr/volumes/69/wr/mm6947e1.htm